Hepatitis A Author: Catherine M. Dentinger, FNP, MS; Brian J. McMahon, MD, MACP
Editorial changes - 2009-11-04
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools
Follow-up

Monitor patients with uncomplicated hepatitis A for clinical improvement. C

  • Ask about:
    • Fatigue, return to normal activities
    • Weight loss
    • Improvement in acute symptoms, including nausea, vomiting, abdominal pain, anorexia, and skin and sclerae color
  • Look for resolution of jaundice, icterus, hepatomegaly, and splenomegaly.
  • Monitor AST and ALT levels until they return to normal.
  • See table Elements of Follow-up for Hepatitis A.
Background

FAQs
Brian J. McMahon, MD, MACP has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations. Catherine M. Dentinger, FNP, MS has no financial relationships with pharmaceutical companies, biomedical device manufacturers, or health-care related organizations.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.